Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Kino Lilly Jr. had 16 points in Brown’s 98-57 victory against Johnson & Wales on Sunday. Lilly also added eight assists for ...

Macupatide (LY-3532226) is under development for the treatment of type 2 diabetes, obesity and type 1 diabetes mellitus. It is administered through subcutaneous route. It is a long acting new ...

LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I drugs for Cervical Cancer have an 80% phase transition ...

Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...

Amazon.com’s Prime Video streaming service has licensed what it said was a documentary about former and future first lady ...

I wrote an article about which stocks to avoid in 2024. Check out how well I did with my predictions versus S&P 500.

This top healthcare company trades at 13 times forward earnings. It has a diverse portfolio of products, yields 3.6% at the ...

Some stocks' price-to-earnings valuations declined even as they outpaced the S&P 500's big gain The most commonly cited valuation measure for stocks is the forward price-to-earnings ratio. This is a ...

U.S. health-related news updates include: a $306 million investment for bird flu monitoring, a new advisory on alcohol's ...

Milwaukee's 2025 construction plans include mall redevelopments, housing, hotels, and more. Meanwhile, megaprojects flourish ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...